Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
03/09/2026 15:28
BRIEF-Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio Sept 3 (Reuters) - Cohance Lifesciences Ltd COHA.NS:
INVESTMENT OF USD 18 MILLION IN NJ BIO AND ARUKA BIO
TO BUY 244,587 NJ BIO SHARES AT $53 PER SHARE FOR $13 MILLION
Source text: ID:nBSEGxWmZ
Further company coverage: COHA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss